Brolucizumab in recalcitrant neovascular age-related macular degeneration-real-world data in Chinese population. Weng CC, Chi SC, Lin TC, Huang YM, et al. PLoS One 2024;19:e0301096.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Weng CC, Chi SC, Lin TC, Huang YM, et al. Brolucizumab in recalcitrant neovascular age-related macular degeneration-real-world data in Chinese population. PLoS One 2024;19:e0301096.
PMID: 38564612